Programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blockers and other ICI have been listed as standard treatment options for multiple types of cancer (2–4). The gene discussed is CTLA4; the disease is cancer.